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Open access under the ElsHb S-São Paulo (SP) [HBB:c.20A > T p.Glu6Val; c.196A > G p.Lys65Glu] is a new double-mutant hemoglo-
bin that was found in heterozygosis in an 18-month-old Brazilian male with moderate anemia. It behaves
like Hb S in acid electrophoresis, isoelectric focusing and solubility testing but shows different behavior in
alkaline electrophoresis, cation-exchange HPLC and RP-HPLC. The variant is slightly unstable, showed
reduced oxygen afﬁnity and also appeared to form polymers more stable than the Hb S. Molecular
dynamics simulation suggests that the polymerization is favored by interfacial electrostatic interactions.
This provides a plausible explanation for some of the reported experimental observations.
 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Hemoglobin S (Hb S, or bs globin) results form a single nucleo-
tide mutation (CTG? GAG) in the sixth codon of the b-globin gene
that causes glutamic acid to be substituted by valine on the surface
of the variant b chain. This change allows Hb S to polymerize when
deoxygenated because the valine residue favors hydrophobic inter-
actions between adjacent globin chains [1].
The presence of this mutation in homozygosis (Hb S/Hb S) and in
a number of compound heterozygous conditions with common Hb
C, Hb E, Hb D Punjab, Hb O-Arab and beta thalassemia traits, results
in a group of common clinical manifestations known as sickle cell
disease (SCD).1 Polymerization of deoxygenated Hb S is the primary
indispensable event in the molecular pathogenesis of sickle-cellClinical Pathology, School of
(UNICAMP), Campinas, P.O.
55 19 3521 9434.
nati@fcm.unicamp.br (M.F.
nitric oxide; MD, molecular
e liquid chromatography; RP-
graphy.
evier OA license.disease, as it triggers a cascade of vaso-occlusions and hemolysis
abetted by elements of inﬂammation, oxidant damage, deregulated
homeostasis of nitric oxide (NO) and endothelial-cell injury [2,3].
Heterozygous individuals (AS) are usually free of clinical
symptoms because of the abundance of Hb A in erythrocytes
(approximately 60%), which prevents polymerization of Hb S un-
der physiological conditions. The same asymptomatic behavior
can be observed in heterozygous carriers of four sickling Hb
variants with a double mutation (b6 Glu? Val and other residue
substitutions at the same beta-globin): Hb C-Ziguinchor
[HBB:c.20A > T p.Glu6Val; c.176C > G p.Pro58Arg], Hb C-Harlem
[HBB:c.20A > T p.Glu6Val; c.220G > A p.Asp73Asn], Hb S-Oman
(b6 [HBB:c.20A > T p.Glu6Val; c.364G > A p.Glu121Lys] and Hb S-
Travis [HBB:c.20A > T p.Glu6Val; c.428C > T p.Ala142Val] [4–7].
However, two other double-mutant variants that cause sickling
in heterozygotes, namely, Hb S-Antilles [HBB:c.20A > T p.Glu6Val;
c.70G > A p.Val23Ile] and Hb Jamaica Plain [HBB:c.20A > T p.Glu6-
Val; c.205C > T p.Leu68Phe], cause their carriers moderate and se-
vere anemia, respectively, as well as splenomegaly [8,9]. These
mutant proteins differ from others in their decreased afﬁnity for
oxygen, which can enhance polymerization of the Hb S variant
and lead to manifestations of the sickle cell disease even in simple
heterozygotes [8,9].
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S-São Paulo (Hb S-SP), a new double-mutant variant with altered
functional behavior that displays the sickle mutation b6 Glu? Val
(A3) and a new substitution, b65 Lys? Glu (E5). We also carried
out molecular dynamics (MD) computer simulations, a molecular
modeling technique widely used to study protein structure and
dynamics [10], in order to investigate the structural features
and conformational adaptations of the new Hb S double mutant
and thus gain insights into its functional behavior from a molec-
ular-level perspective.Material and methods
An 18-month-old Brazilian boy with clinical features of sickle
cell disease who was referred to the School of Medical Sciences
Hospital at the State University of Campinas, in Campinas, state
of São Paulo, southeastern Brazil, for investigation of hemoglobin-
opathies. His hematological parameters are shown in Table 1.
Protein characterization
After informed consent had been obtained from the patient’s
mother, alkaline hemoglobin electrophoresis was performed on
cellulose acetate with Tris–EDTA-boric acid buffer at pH 8.9, and
acid electrophoresis was carried out in agar gel with sodium citrate
buffer at pH 5.8. Isoelectric focusing (IF, RESOLVE TM Systems,
Neonatal Hemoglobin Test Kit, Perkin Elmer-Wallace, Akron, OH,
USA) was also used to distinguish the anomalous protein from
the normal fraction. In addition, cation exchange-high perfor-
mance liquid chromatography (CE-HPLC) (VARIANT™; Bio-Rad
Laboratories, Hercules, CA, USA) was used to quantify hemoglobin
concentrations. Hb A2 was measured by elution from cellulose ace-
tate after electrophoresis at alkaline pH [11]. Globin chains were
analyzed by reverse phase-high performance liquid chromatogra-Table 1
Hematological, biochemical and molecular data of the patient and his mother and sister.
Proband
Age (years) 1.5 (18 months old)
RBC (106/mm3) 3.73
Hba (g/dL) 8.9
Hcta (%) 29.2
MCVa(ﬂ) 78.3
MCHa (pg) 23.9
RDWa (%) 18.5
Reticulocytes (%) 1.51
Electrophoresis (cellulose acetate, pH
8.9) and CE-HPLCa proﬁles
Hb A2,Hb F, Hb A, Hb Xb
Hb A2 (%) 2.72d
Hb F (%) 12.3
Hb X (%) or Hb S (%) Hb X = 29.2
Acid electrophoresis proﬁle (agar gel,
pH 5.8)
Hb A, Hb F, Hb Xb
RP-HPLCa (% of globin-chains) HEME = 10.44, d = 2.22%, b = 24.58%, bx = 11.
a = 45.79%, cG = 2.19% cA = 3.31%
Solubility test Reduced solubility
Stability tests Slightly unstable Hb
Mutations found in the b-globin genes codon 6 (b) GAG-GTGc
codon 65 (b)AAG-GAGc
codon 2 (b)C-Tc
(in cis)
a Genotypea aa/aa
a RBC = Red Blood Cells; Hct = Hematocrit (packed red blood cell volume); MCV = Me
Erythrocytes; RDW = Red Cell Distribution Width of Erythrocytes; CE-HPLC = Cation E
Performance Liquid Chromatography; a Genotype = a-Globin Gene Genotype.
b Hb X = Hb S-São Paulo.
c Heterozygosis.
d Measured by elution from cellulose acetate after electrophoresis at alkaline pH.
e These high values do not indicate a beta thalassemia trait but are an artifact due tophy (RP-HPLC) on a Waters Alliance HPLC system (Waters, Milford,
MA, USA). Heinz body, stability (heat, isopropanol and n-butanol)
and solubility tests were carried out using standard procedures
[11]. Polymerization of Hb S-SP was monitored by spectrophotom-
etry at 700 nm, as described by Adachi and Asakura [12], for 24 h.
The tests were carried out at 30 C with stripped hemolysate at a
concentration of 0.123 g/dL in the presence of 1.8 M phosphate
buffer at pH 7.34 in a hermetically sealed tube to avoid contact
with oxygen and thus minimize the inﬂuence of Hb F on Hb S-SP
polymerization. The results were compared with those obtained
using the stripped hemolysate of heterozygous Hb S at the same
concentration.
Molecular analysis of HBB
The gene mutation was identiﬁed using genomic DNA obtained
from peripheral leukocytes (Blood Genomic Prep Mini Spin, GE
Healthcare, Amersham, UK). Beta-globin gene sequencing was per-
formed with an automated sequencer (ABI PRISM™ 377 DNA Auto-
mated Sequencer, Applied BioSystems, Foster City, CA, USA) using
primers described elsewhere [13]. The mutations were conﬁrmed
by reverse DNA sequencing and by cloning techniques using the
pGEM-T Easy Vector kit (Promega, Madison, WI, USA). Concomi-
tant a-thalassemia was excluded by performing multiplex gap-
PCR for the most common deletions [14]. Likewise common non-
deletional mutations were excluded by a combination of speciﬁc
PCR assays and restriction enzyme analysis [15].
Function tests
The functional behavior of the erythrocyte hemolysate (in the
stripped state and at a concentration of 70 lM/Heme) was
analyzed by the Rossi-Fanelli and Antonini method [16] at 25 C.
Puriﬁcation of the total hemolysate was performed using SephadexMother Sister
31 10
4.9 5.18
13.9 13.6
38.9 39.5
79.4 76.3
28.4 26.3
13.4 12.4
0.6 0.53
Hb A2, Hb S, Hb A Hb A2, Hb S, Hb A
4.4e 4.4e
0.6 0.3
Hb S = 38.6 Hb S = 37.7
Hb A, Hb S Hb A, Hb S
47%, HEME = 10.15,d = 2.28%,
b = 23.66%, bs = 18.32%, a = 45.59%
HEME = 9.99, d = 2.46%, b = 24.32%,
bs = 17.58%, a = 45.65%
Reduced solubility Reduced solubility
Normal Normal
codon 6(b) GAG-GTGc
codon 2 (b)C-Tc
(in cis)
codon 6(b) GAG-GTGc
codon 2 (b)C-Tc
(in cis)
aa/aa aa/aa
an Corpuscular Volume of Erythrocytes; MCH = Mean Corpuscular Hemoglobin of
xchange-High Performance Liquid Chromatography; RP-HPLC = Reverse Phase-High
overlapping of the glycated Hb S with the (normal) Hb A2 [35].
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ethyl) piperazine-N0-2-ethane sulfonic acid) buffer (Sigma–Aldrich,
St. Louis, MO, US) without addition of NaCl. Oxygen equilibrium
curves in the absence and presence of inositol hexaphosphate were
plotted (IHP, 0.1 mM) (Sigma–Aldrich, St. Louis, MO, US). Oxygen
afﬁnity (determined by measuring p50), Bohr Effect, and coopera-
tivity (by Hill plot) were analyzed according to previously
described methods [16,17]. The results obtained were compared
with the results for hemolysates from normal human adult red
cells that contained mainly stripped Hb A (95%).
Functional tests at pH 7.34 were also carried out using a Hemox
Analyzer (TCS Medical Products Division, Southampton, PA). In
these analyses we used 20 lL of red blood cell concentrate stored
at 80 C, to which Hemox buffer solution (TCS Medical Products
Division) was added as recommended by the manufacturer. The
results for afﬁnity and cooperativity obtained with the hemolysate
containing the Hb S-SP were compared with the hemolysate con-
taining the normal standard, the hemolysate containing the control
heterozygous Hb S and the hemolysate containing standard 100%
Hb F, all of which were also stored at 80 C for the same time.
In addition, tests with the polymerized Hb S-SP fraction were
also carried out in pH 7.34 using the Hemox Analyzer. The poly-
merized variant was isolated using a solubility test, as previously
described [11]. The results obtained were compared with the con-
trol heterozygous Hb S fraction isolated in its T conformation by
the same method.
It should be stressed that in the case of the Hemox Analyzer no
protein puriﬁcation was carried out, unlike in earlier functional
studies. Nevertheless, all the samples were subjected to the same
conditions, and the method and reagents recommended by the
manufacturer were used.
Molecular dynamics simulation
MD simulations were performed to probe the structural pertur-
bation introduced by S and SP mutations on Hb structure and poly-
merization. All simulations were performed using the following
protocol: Crystallographic models or computational constructs of
the mutants (see below) were solvated with water and sodium
and chloride ions with Packmol [18] by deﬁning a 15 Å layer of
water and an ionic concentration that neutralizes the system and
mimics a physiological salt concentration of 0.15 M. The solvated
systems were equilibrated and simulated with NAMD using
CHARMM parameters [19], periodic boundary conditions, a cutoff
of 12 Å for van der Waals interactions with a switching function
starting at 10 Å and the particle mesh Ewald method for long-
range electrostatic interactions. Simulations were performed under
constant pressure using a Langevin piston at 1 atm with a 200 fs
period, a 100 fs decay, and 298.15 K temperature. The temperature
of the simulated systems was set 298.15 K by velocity rescaling at
every 100 steps for equilibration runs, or by the application of a
Langevin bath with a damping period of 2 ps1 for production runs.
A time-step of 2.0 fs was used, while keeping bonds to hydrogen
atoms rigid using SHAKE [20]. Equilibration was performed as fol-
lows: First, the total energy of each system was minimized by 2000
steps of Conjugate-Gradients (CG) followed by 200 ps MD, while
keeping all protein atoms ﬁxed. Next, the side-chains of the pro-
teins were allowed to move, and 200 steps of CG minimization
and 200 ps MD were performed. Finally 5 ns runs using the pro-
duction run protocols were performed for each system. The ﬁnal
conﬁguration of these last runs were used as starting conditions
for 15 ns production runs, which were used for analysis.
Crystallographic models of Oxy and Deoxy Hb were used (PDB
ids. 2DN1 and 2DN2 and, respectively, both with 1.25 Å resolution)
[21]. Simulations were performed for both native and double (S-
SP) mutants, which were constructed by the substitution of the na-tive with the mutant side chain using VMD [22]. The full Hb was
simulated (four chains), and the mutations were introduced in
each b-chain. Each of these systems had approximately 72,000
atoms. Simulations were also performed with the structure crystal-
lographic model for the Hb S dimmer (eight chains) (PDB. id. 2HBS,
2.05 Å resolution) [23], as well as for the computational construct
of the double mutant Hb S-SP dimmer (eight chains), where the
K65E mutation was introduced on all b-chains. These systems con-
tained about 168,000 atoms.
Structure ﬁgures were done with VMD [22], and home-made
software (http://lm-mdanalysis.googlecode.com) was used for
analysis. The distances in Fig. 6 were computed considering the
side-chain nitrogen atom of Lys residues and the carboxylate car-
bon atoms of Glu and Asp residues.Results
Protein characterization
Alkaline electrophoresis revealed Hb A, Hb F and Hb A2 bands
and an abnormal band faster than Hb A (with a pI of 6.68 in the
IF) (Fig. 1A), while acid electrophoresis revealed a band with elec-
trophoretic mobility similar to that of Hb S. This abnormal fraction
eluted as a peak in the D window in CE-HPLC (Fig. 1B) and repre-
sented 29.6% of the total hemoglobin. Globin-chain analysis by
RP-HPLC detected an anomalous b-chain that eluted more slowly
than the normal b-chain and represented 11.47% of the total hemo-
globin (Fig. 1C). The results of the solubility test were compatible
with the presence of Hb S and those of the stability tests with
the presence of a slightly unstable fraction. Lastly, analysis of Hb
S-SP polymerization by spectrophotometry indicated that the
delay time for Hb S-SP polymerization was not signiﬁcantly differ-
ent from the polymerization time for Hb S (Fig. 2A). However, the
absorbance values of the Hb S-SP polymers formed were signiﬁ-
cantly higher than those of the Hb S polymers even after 24 h, indi-
cating that the Hb S-SP polymer is quite stable (Fig. 2A and B).
Molecular analysis of HBB
Sequencing of the b-globin gene (OMIM ID:141900) revealed
both a GAG? GTG transition at codon 6 and an AAG? GAG tran-
sition at codon 65, on the same allele, in heterozygosity, corre-
sponding to the Glu? Val replacement at the 6th position and
Lys? Glu at the 65th position of the of the b-globin, respectively.
The common C? T polymorphism at codon 2 was also observed in
cis with the double mutation [HBB:c.20A > T p.Glu6Val; c.196A > G
p.Lys65Glu; SNP rs713040]. Familial analysis indicated that the pa-
tient’s mother and sister had sickle cell trait, as well as the C? T
polymorphism at CD2. Cloning techniques conﬁrmed that both
mutations and the polymorphism were present in the same allele
of the proband, who inherited the maternal b6Glu? Val allele in
addition to the new mutation (b65Lys? Glu) (Fig. 1D), which
probably occurred later on the same chromosome (perhaps in
the germ line cells of the mother). Concomitant a-thalassemia
was excluded by gap-PCR for the most common deletion and
non-deletional mutations, on the proband as well on his mother
and sister. The father was not available for the study, however,
he was asymptomatic. The hematological, biochemical and molec-
ular data of this family are summarized in Table 1.
Function tests
As shown in Fig. 3A, functional tests performed with the
stripped hemolysate revealed reduced oxygen afﬁnity in the
absence of IHP although Hb F, which should confer lower p50
Fig. 1. Protein and molecular characterization of Hb S-SP. (A) Electrophoresis at alkaline pH of patient’s hemolysate revealed Hb S-SP, Hb A and traces of Hb F and Hb A2; (B)
Cation exchange-high performance liquid chromatogram (CE-HPLC) of Hb S-SP; (C) Reverse phase-high performance liquid chromatogram (RP-HPLC) of Hb S-SP. d, b, a, cG, cA
correspond to delta, beta, alpha, Ggamma and Agamma chains, respectively. bx corresponds to the mutant chain [b6 (A3) Glu? Val; b65 (E5) Lys? Glu]; (D) Sequencing
chromatograms revealing two clones derived from the patient’s DNA: (1) Wild Type Clone; (2) Clone containing the sickle mutation b6 GAG? GTG and the spontaneously
arising mutation b65 AAG? GAG, indicating that both mutations were on the same chromosome.
Fig. 2. Polymerization kinetics and stability of Hb S polymers (in black) and Hb S-SP polymers (in red), in 1.8 M PO4 buffer (pH 7.34) at 30 C, indicating that Hb S-SP polymers
have signiﬁcantly greater stability than the Hb S control for (A) 90 min; (B) 24 h. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
26 S.E.D.C. Jorge et al. / Archives of Biochemistry and Biophysics 519 (2012) 23–31especially in the presence of organic phosphates, was present at a
concentration of 12.3% [24]. When IHP was added to the stripped
hemolysate we observed a small increase in the afﬁnity of the var-iant for oxygen in alkaline pHs (>8), resulting in a small increase in
the Bohr effect (Fig. 3B). The increase in afﬁnity may be a conse-
quence of the increased concentration of Hb F, as this protein
Fig. 3. Functional characterization. (A) Higher partial pressure of oxygen (pO2) at pH 7.5 of stripped hemolysate containing Hb S-SP compared with the wild type Hb A; (B)
Bohr effect of Hb S-SP in relation to the total hemolysate of a human adult, made up mainly of Hb A, showing the partial afﬁnity of the hemoglobin (p50) as a function of pH in
the presence and absence of IHP; (C) Variation in cooperativity (Hill plot) with pH in the presence and absence of IHP.
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occupies the same active site as 2,3 BPG and has greater chemical
stability [25,26]). However, The Hill’s coefﬁcient (n), which is indic-
ative of heme–heme cooperativity, was higher in the absence of IHP
and considerably lower in the presence of IHP when compared
with the Hb A values (Fig. 3C).
Functional studies in a Hemox Analyzer using red blood cell
concentrate conﬁrmed the reduced O2 afﬁnity of Hb S-SP observed
in the previous experiments (in its stripped state). In addition,
these analyses once again showed the increased O2 afﬁnity of Hb
F as well as values of O2 afﬁnity considered normal for Hb S in het-
erozygosis (Fig. 4A and B) [27] The p50 values obtained from the
curves are shown in the table of results in Fig. 4A and B.
Automated functional tests with Hb SP-P isolated in a solubility
test revealed more clearly the reduced O2 afﬁnity of the variant
(Fig. 4C and D), and showed reduction in heme–heme cooperativity
compared with the total hemolysate, as the Hb S polymer (Fig. 5).
Molecular dynamics simulation
We performed simulations of Oxy-Hb and Deoxy-Hb, in the na-
tive and double-mutant (Hb S-SP) forms. Each simulation was
20 ns long, being equilibrated in the ﬁrst 5 ns run. The residue in
position 65 of the Hb b-chains is located in Helix E oriented to
the solvent. In both native Oxy-Hb and Deoxy-Hb, it participates
in an effective electrostatic interaction with residue Asp21, as
shown in Fig. 6A. Since the SP mutation inverts the electrostatic
charge of Lys65, it may readily affect this interaction. Indeed, oursimulations show that in both Oxy-Hb and Deoxy-Hb the distance
between residue in position 65 (Lys or Glu) and Asp21 increases, as
shown by the displacement of distribution curves in red in Fig. 6B
and C. The shift of these electrostatic bonds allow for the favorable
approach of mutant Glu65 with the side chain of Lys66, as shown
by distance distributions in black in Figs. 6B and C. Since the Helix
E residues discussed above are located close to the active site, they
could have some direct implication in oxygen afﬁnity [28,29].
However, within the time-scale of our simulations, no perturbation
in His63 was observed (Supplementary Fig. S1), thus this possibil-
ity is not supported by the present study.
In addition, we probed the possible effect of the b65 Lys? Glu
mutation on Hb polymerization, which is known to take place in
Hb-S alone. We simulated the crystal structure of the Hb S dimer
and a computational construct of the double mutant dimer
(Fig. 7A). This crystallographic dimer putatively displays the dimer-
ization surface leading to Hb S polymerization. The b65 Lys? Glu
mutant is located in the proximity of the dimer interface, thus pos-
sibly affecting dimer stability. In Fig. 7A the residue in position 65 is
depicted with van der Waals spheres. The residues of the upper di-
mer that are closer to the mutant residue are shown by a surface
representation, and belong to a b-chain. In Fig. 7A and B, residues
that interface with position 65 are colored by type; positively
charged residues are shown in blue, and negatively charged resi-
dues in red. There are two negatively charged residues (Glu7 and
Asp79), and four positively charged ones (Lys8, Lys82, Lys132,
and N-terminal Val1). Therefore, there is a net positive charge at
this surface, and the b65 Lys? Glu substitution at the neighboring
Fig. 4. Automated functional tests. (A) Comparison of the oxygen dissociation curves and values corresponding to p50 (mmHg) of the total hemolysates. (B) Comparison of
the hemoglobin oxygen saturation curves and values corresponding to p50 (mmHg) of the total hemolysates. (C) Comparison of the oxygen dissociation curves and values
corresponding to p50 (mmHg) of the Hb S and Hb S-SP fractions isolated in their T form by the formation of polymers obtained from the solubility test. (D) Comparison of the
hemoglobin oxygen saturation curves and values corresponding to p50 (mmHg) of the Hb S and Hb S-SP fractions isolated in their T form by the formation of polymers
obtained from the solubility test.
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Hb S dimer. We have performed simulations of the Hb S and the
computational construct of Hb S-SP dimer, each lasting 20 ns. The
structure of the dimer is stable in this time scale, but the interaction
energy proﬁles of residue in position 65 with the nearby b-chain
surface indicate that this interaction may facilitate polymerization.
Because of the net positive charge of the interface, the interaction of
the interfacial residues with Glu65 (left side of graph, black line) isstrongly attractive, whereas interactions with Lys65 (right side,
black) are strongly repulsive, as shown in Fig. 7C. These highly dif-
ferent interaction proﬁles result from the interaction with charged
residues (Fig. 7C, red lines), but were also reinforced by a favorable
shift in interaction proﬁles for neutral residues (Fig. 7C, blue). Not
unexpectedly, these pronounced shifts in electrostatic interactions
may be softened by solvent reorientation and ion placement. How-
ever, these interactions also suggest that the dimer of Hb S-SP could
Fig. 5. Heme–heme cooperativity at pH 7.34 measured by the automated method. (A) Hill’s coefﬁcient obtained from the oxygen dissociation and saturation curves. (B)
Graphical representation of the Hill’s coefﬁcients (n) obtained in this way.
Fig. 6. Intramolecular interactions of the Hb S-SP and their possible perturbation of His7e conformation. (A) Residue in position 65 can interact either with Asp21 or Lys66,
and is located on Helix E, which contains His7e. (B and C) Mutation of positively charged Lys65 to Glu disrupts the K65-D21 interaction and leads to the approach of the Glu65
side chain to Lys66, both in Oxy-Hb (B) and Deoxy-Hb (C) simulations; arrows indicate the shift in distance distributions promoted by mutations.
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thus facilitating the nucleation process that leads to protein
polymerization.
Discussion
Hb S-São Paulo is a novel double-mutant human hemoglobin
that results in moderate anemia in its carrier. This slightly unstable
variant has two substitutions in the same b-chain [b6 (A3) Glu?
Val and b65 (E5) Lys? Glu] and has reduced oxygen afﬁnity. Fur-
thermore, we suggest that Hb S-SP polymers formed in erythro-
cytes are more stable than Hb S polymers. This hypothesis was
reinforced by the considerable stability exhibited by the Hb
S-SP polymers in the spectrophotometric and molecular dynamic
analysis (Figs. 2 and 7).
Both the functional tests carried out by the spectrophotometric
method, with stripped hemolysate in the absence of IHP, and the
automated method using a Clark electrode with total hemolysate
in physiological conditions, revealed a reduced O2 afﬁnity in
hemolysate containing Hb S-SP (Figs. 3A and B and 4A and B).
However, in the presence of IHP, the functional behavior of the
hemolysate containing Hb S-SP was similar to that of Hb A at a
pH below 8 (Fig. 3B). It is possible that the Hb F concentration
(12.3%) in the stripped hemolysate studied here minimized the re-duced oxygen afﬁnity of Hb S-SP, since it is well known that fetal
human hemoglobin has lower afﬁnity for 2,3 BPG and is therefore
more readily available for oxygen interaction [24] (Fig. 3B). Auto-
mated functional tests support the hypothesis that Hb F interferes
with the afﬁnity of the total hemolysate (Fig. 4A and B), as when
Hb S-SP was isolated from the other fractions by polymerization
in a low-oxygen-content environment (in the solubility test) it
showed quite reduced O2 afﬁnity (Fig. 4C and D) compared with
Hb A hemolysate, the Hb A/Hb F/Hb S-SP hemolysate, the Hb A/
Hb S hemolysate and the Hb S polymer resuspended in Hemox
solution.
The results for heme–heme cooperativity of Hb S-SP obtained by
spectrophotometry and the automated method were also concor-
dant. An increase in the Hill’s coefﬁcient was observed in both
analyses (Figs. 3C and 5). This is probably due to the presence of
the Val6 substitution, which confers increased heme–heme cooper-
ativity before the stable polymer is formed [30,31]. However, the
Hill’s coefﬁcient observed in the presence of IHP was considerably
decreased than that for Hb A. Possibly the high concentration of Hb
F was responsible for the decreased heme–heme cooperativity of
Hb S-SP as a result of its known reduced afﬁnity for 2,3 BPG and
lower heme–heme cooperativity [24,27]. Another interesting ﬁnd-
ing is that, as with the Hb S polymer, the Hill’s coefﬁcient of the
Hb S-SP polymer was reduced, indicating non-cooperative O2 bind-
Fig. 7. The effect of the SP mutation on the Hb S dimer and its possible role on Hb polymerization. (A) The SP mutation is located at the vicinity of the dimer interface of Hb S,
believed to be implied in the polymerization in cells. (B) Residues at the b-chain of the upper Hb S are electrically unbalanced. Four positively charged residues (blue) are close
to position 65 of the Hb S, while only two negatively charged residues (red) belong to this interface. (C) The unbalanced charged promote strongly favorable (negative)
electrostatic interactions of the interfacial residues with mutant Glu65, and strongly repulsive interactions with native Lys65, suggesting that the SP mutant might provide an
additional contribution for dimer stabilization and thus Hb S-SP polymerization. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
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needed to conﬁrm the results for cooperativity and correlate them
to the polymerization properties of Hb S-SP (Figs. 2 and 7).
Our MD simulations suggest that the Hb S-SP mutant affects the
residue side-chain dynamics in Helix E and could. The most rele-
vant perturbation appears to be an important shift in electrostatic
interactions of the residue in position 65: while native Lys65 inter-
acts strongly with Asp21 of the same b-chain, charge inversion on
Glu65 leads to repulsion and a tendency of the mutant residue to
interact with Lys66. The SP mutant is close to the dimer interface
of crystallographic Hb S, which is believed to represent the interac-
tion leading to sickle-cell Hb S polymerization, as shown by a pio-
neering molecular dynamics simulation study [32]. The residues in
the dimer interface region in the proximity of the SP mutation have
a positive net charge, as a result of which mutation of b65 Lys? -
Glu causes a signiﬁcant shift in the proﬁle of electrostatic interac-
tions in this region. This suggests that Glu65 may induce an
additional stabilization of the dimer, thus promoting nucleation
and the subsequent polymerization of the protein.
In summary, we have identiﬁed a new double-mutant hemoglo-
bin in heterozygosis showing moderate anemia in an 18-month-
old Brazilian male. A similar clinical picture is produced by Hb S-
Antilles [HBB:c.20A > T p.Glu6Val; c.70G > A p.Val23Ile] and Hb Ja-
maica Plain [HBB:c.20A > T p. Glu6Val; c.205C > T p.Leu68Phe],
variants that also have reduced oxygen afﬁnity and greater poly-
merization potential [8,9]. Like Hb S-SP, Hb S-Antilhes also pro-
duced abnormal results in polymerization tests [8,9]. However,
whereas Hb S-Antilles had higher polymerization speeds than Hb
S in tests lasting 50 min [33], the Hb S-SP stripped hemolysate
had the same polymerization speed as Hb S when tested for
60 min but greater stability, and polymerized continuously up to
90 min (Fig. 2). These ﬁndings are supported by computer simula-
tions of Hb S-SP, which suggest that the substitution of Lys by Glu
at residue 65 of the b-chains leads to the formation of more stable
dimers than those in Hb S polymers.This study allowed us to assess the deterioration in the clinical
picture of this Hb S-SP carrier caused by the second mutation. In
Brazil, it is important to bear in mind the possibility of combined
mutations because of the high prevalence of hemoglobinopathies
due to the extensive miscegenation and racial diversity of the Bra-
zilian population [34]. The concomitant appearance of Hb S-SP
with other variants (such as Hb S or even Hb C, which in heterozy-
gosis result in an asymptomatic phenotype) or even beta thalasse-
mia can very possibly result in a more severe clinical picture.
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